J. Goldman & Co’s Amgen AMGN Stock Holding History

J. Goldman & Co’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,000	Closed	-$2.82M	–	555
2025 Q3	$2.82M	Sell	10,000 -19,200	-66%	-$5.57M	0.07%	251
2025 Q2	$8.15M	Sell	29,200 -82,100	-74%	-$23.3M	0.2%	152
2025 Q1	$34.7M	Buy	+111,300	New	+$32.9M	0.86%	18
2024 Q4	–	Sell	-20,000	Closed	-$6.44M	–	450
2024 Q3	$6.44M	Buy	+20,000	New	+$6.54M	0.18%	139
2024 Q2	–	Sell	-20,000	Closed	-$5.69M	–	436
2024 Q1	$5.69M	Buy	20,000 +17,000	+567%	+$4.97M	0.18%	140
2023 Q4	$864K	Sell	3,000 -37,000	-93%	-$10.1M	0.04%	239
2023 Q3	$10.8M	Buy	+40,000	New	+$9.98M	0.38%	85

Other funds holding AMGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J. Goldman & Co's AMGN Position: Q1 2026 in Review

J. Goldman & Co reduced its Amgen (AMGN) stake by 77% in Q1 2026, selling an estimated $12M and leaving 9,900 shares worth $3.48M. The position accounts for 0.1% of the portfolio, ranked #236.

J. Goldman & Co first reported a position in AMGN in Q2 2022 and has held it in 10 quarters since. The position peaked at $27.8M in Q3 2023. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

J. Goldman & Co held 9,900 shares of Amgen worth $3.48M as of Q1 2026.
J. Goldman & Co sold 33,588 Amgen shares in Q1 2026, an estimated $12M.
Amgen made up 0.1% of J. Goldman & Co's portfolio in Q1 2026, its #236 holding.
J. Goldman & Co first reported a position in Amgen in Q2 2022 and has held it in 10 quarters since.
J. Goldman & Co's Amgen position peaked at $27.8M in Q3 2023.
3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.